Biosimilars can not only reduce patients' financial burdens, but also encourage more people to go for early diagnosis and ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...

Amneal announced FDA acceptance of its Biologics License Application (BLA) for two proposed denosumab biosimilars ...

The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).

India has a strong pharma network, with more than 10,000 manufacturing facilities, over 3,000 pharma companies.

Finance Minister Thangam Thennarasu on Friday (March 14, 2025) said to boost tourist arrivals in south Tamil Nadu and promote ...

The initiative aims to boost tourism in South Tamil Nadu and contribute to the economic development of the region ...

The US Food and Drug Administration (FDA) has approved Celltrion’s biosimilars referencing Amgen’s bone disease therapy ...

The bioengineered protein drugs market is experiencing a paradigm shift, with pharmaceutical and biotech companies leveraging ...

The company emphasized its strategic focus on biosimilars, noting significant investments and a robust pipeline targeting a $200 billion market. While Alvotech highlighted successful product ...